A Review of Septic Shock

Hardaway, Robert M.
January 2000
American Surgeon;Jan2000, Vol. 66 Issue 1, p22
Academic Journal
The mortality of septic shock, both in percentage of septic shock cases and total number of septic shock cases, has been increasing over the past several decades. This is despite major advances in diagnosis and treatment. The basic cause of traumatic and septic shock has only partially been elucidated. This review presents information about the basic cause and mechanism of septic shock as well as a new treatment based on this information. Data sources include research papers on the subject of septic shock from 1875 until the present. These papers numbered more than 10,000, most of which are not included in the reference list because many are duplicative. The main result of the review of literature is that all of a wide variety of treatments of septic shock have not resulted in a lowering of mortality, but in fact have increased it. Another toxin (in addition to endotoxin and its secondarily induced host mediators) is proposed. This toxin causes disseminated intravascular coagulation, which may obstruct the microcirculation of any and all organs, producing multiple organ failure by microclots. These microclots may be lysed by plasminogen activator and circulation to the organs restored.


Related Articles

  • Anandamide absorption by direct hemoperfusion with polymixin B-immobilized fiber improves the prognosis and organ failure assessment score in patients with sepsis. Kohro, Shinji; Imaizumi, Hitoshi; Yamakage, Michiaki; Masuda, Yoshiki; Namiki, Akiyoshi; Asai, Yasuhumi; Maruyama, Ikuo // Journal of Anesthesia;2006, Vol. 20 Issue 1, p11 

    The article presents a study which aims to clarify the mechanism of PMX-DHP effect on septic shock. The study was conducted at conducted at Sapporo Medical University and three community hospitals in Japan from January 2000 to December 2002. Treatments including regular antibiotic therapy were...

  • The Pathogenesis of Vasodilatory Shock. Landry, Donald W.; Oliver, Juan A. // New England Journal of Medicine;8/23/2001, Vol. 345 Issue 8, p588 

    Discusses vasodilatory shock, or septic shock. Characteristics, including hypotension and poor response to therapy with vasopressor drugs; Causes; Mechanisms promoting vasodilation in vasodilatory shock; Conclusion that effective treatment is possible if the initiating event is controlled and if...

  • Procalcitonin-guided algorithm to reduce length of antibiotic therapy in patients with severe sepsis and septic shock. Hohn, Andreas; Schroeder, Stefan; Gehrt3, Anna; Bernhardt, Kathrin; Bein, Berthold; Wegscheider5, Karl; Hochreiter, Marcel // BMC Infectious Diseases;2013, Vol. 13 Issue 1, p1 

    Background: Procalcitonin (PCT)-protocols to guide antibiotic treatment in severe infections are known to be effective. But less is known about the long-term effects of such protocols on antibiotic consumption under real life conditions. This retrospective study analyses the effects on...

  • Companiesandmarkets.com: Prevalence Of Infection in Hospitals Increasing Demand for High Efficacy Sepsis Drug Treatments.  // Biomedical Market Newsletter;9/26/2011, Vol. 21, p4 

    The article reports on the prevalence of infection in hospitals to increase the demand for high efficacy of treating sepsis. The report analyzed the types of sepsis and their treatment including severe sepsis, uncomplicated sepsis, bacteremia, septicemia/septicaemia, and septic shock. It notes...

  • Septic shock: treating more than just blood pressure. Mayers, Irvin; Johnson, David // CMAJ: Canadian Medical Association Journal;2/08/2000, Vol. 162 Issue 3, p369 

    Reports on the treatment of septic shock, which occurs when the host's response to infection is excessive. The ultimate aim to prevent sepsis-related multiple organ failure, the primary cause of death; Prospects for therapeutic treatments, including cloned proteins and monoclonal anitbodies.

  • Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis. Annane, Djillali; Bellissant, Eric; Bollaert, Pierre Edouard; Briegel, Josef; Keh, Didier; Kupfer, Yizhak // BMJ: British Medical Journal (International Edition);8/28/2004, Vol. 329 Issue 7464, p480 

    Objective To assess the effects of corticosteroids on mortality in patients with severe sepsis and septic shock. Data sources Randomised and quasi-randomised trials of corticosteroids versus placebo (or supportive treatment alone) retrieved from the Cochrane infectious diseases group's trials...

  • New protocol yields better outcomes.  // Healthcare Risk Management;Mar2008, Vol. 30 Issue 3, p34 

    The article reports on the result of the study conducted by the Barnes-Jewish Hospital in St. Louis, Missouri which focuses on the effectiveness of standardized hospital order set in the management of septic shock.

  • Considering CORTICUS: Hydrocortisone in Septic Shock. Akhtar, Saadia R. // Critical Care Alert;Apr2008, Vol. 16 Issue 1, p3 

    A multicenter, randomized, double-blind, placebo-controlled trial of hydrocortisone replacement in patients with septic shock found no mortality benefit in those patients with inadequate baseline response to corticotropin stimulation.

  • Extended drotrecogin alfa (activated) treatment in patients with prolonged septic shock. Dhainaut, Jean-Francois; Antonelli, Massimo; Wright, Patrick; Desachy, Arnaud; Reignier, Jean; Lavoue, Sylvain; Charpentier, Julien; Belger, Mark; Cobas-Meyer, Michael; Maier, Cornelia; Mignini, Mariano A.; Janes, Jonathan // Intensive Care Medicine;Jul2009, Vol. 35 Issue 7, p1319 

    A correction to the article "Extended drotrecogin alfa (activated) treatment in patients with prolonged septic shock" that is published in the current issue is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics